Apidra
NDC 0088-2500 · sanofi-aventis U.S. LLC
Generic nameinsulin glulisine
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)INSULIN GLULISINE
Strength100 [iU]/mL
Pharmacologic classInsulin Analog [EPC], Insulin [Chemical/Ingredient]
Marketing categoryBLA
Packages
0088-2500-33 — 1 VIAL, GLASS in 1 CARTON (0088-2500-33) / 10 mL in 1 VIAL, GLASS
0088-2500-34 — 1 VIAL, GLASS in 1 CARTON (0088-2500-34) / 10 mL in 1 VIAL, GLASS
Billed under HCPCS
J1817 — Insulin for administration through dme (i.e., insulin pump) per 50 units Medicare Part B payment limit (ASP + 6%): $3.06
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0088-2502 — insulin glulisine, 63083-2019 — DNA Insulin Drops, 63083-2146 — Attention Deficit Mild Drops, 63083-2147 — Attention Deficit Severe Drops, 63083-3037 — Pancreas DB Liquescence